A brain scan produces images of your brain’s structure or function, but those images come with a report full of medical terminology that can feel like a foreign language. The key to understanding your results is knowing that radiologists describe what they see in systematic ways: they note the size and shape of brain structures, look for evidence of shrinkage or damage, check for abnormal deposits or lesions, and assess blood flow patterns. When your doctor hands you a report mentioning terms like “mild cortical atrophy” or “white matter hyperintensities,” these are precise medical descriptions of specific findings—not automatic diagnoses of disease. The difference between what the scan shows and what it means for your health is crucial: a radiologist reports the anatomy and changes visible in the images, while your neurologist interprets whether those changes matter for your diagnosis and treatment. Understanding your brain scan results starts with knowing what type of scan you had, because each technology shows different information.
An MRI (magnetic resonance imaging) reveals the brain’s structure in exquisite detail and can detect subtle changes in tissue. A CT (computed tomography) scan uses X-rays and is faster and better at detecting bleeding or bone changes, but shows less structural detail. A PET (positron emission tomography) scan shows how the brain is functioning—specifically where glucose is being metabolized or where certain proteins have accumulated. Your report will describe findings in one or more of these categories: overall brain size and symmetry, the appearance of the major structures, any abnormalities like tumors or bleeds, and the appearance of white matter (the connecting tissue) versus gray matter (the processing centers). None of these findings automatically means you have dementia or another disease; interpretation depends on your age, symptoms, medical history, and what other tests show.
Table of Contents
- What Do Brain Scans Actually Show?
- Understanding Common Findings in Your Report
- What Brain Scans Reveal About Dementia
- Interpreting Size and Structure Measurements
- What Brain Scans Cannot Tell You
- Biomarkers and Advanced Imaging
- Preparing for and Following Up on Your Scan Results
What Do Brain Scans Actually Show?
MRI uses powerful magnets to create detailed images of brain tissue and is the most common scan for evaluating cognitive changes. Unlike CT, MRI has no radiation, making it safer for repeat imaging. An MRI report will describe the size of the ventricles (fluid-filled spaces inside the brain), the thickness of the cortex (the outer gray matter), the appearance of the hippocampus (critical for memory), and any white matter changes—those appear as bright spots on T2-weighted images and often correlate with small vessel disease or aging. For someone with cognitive concerns, an MRI is typically the first choice because it can detect the specific shrinkage patterns seen in different types of dementia: Alzheimer’s disease often causes hippocampal atrophy, frontotemporal dementia causes frontal or temporal lobe shrinkage, and Lewy body dementia may show relatively preserved hippocampus but other changes. The scan itself takes 30-45 minutes and requires you to lie still inside a tube; the noise and confined space bother some people, which is why some centers offer open MRI, though the image quality is typically lower.
CT scans are faster—they take minutes rather than 30 minutes—but provide less detail of soft tissue. CT is the go-to scan if doctors suspect acute bleeding (from a fall or stroke), a tumor, or a large ischemic stroke, because it shows these catastrophic findings quickly. A CT report describes brain density, symmetry, the size of ventricles, and any areas of low density (which might indicate old stroke or tissue loss) or high density (which might indicate bleeding, calcium deposits, or certain tumors). For dementia evaluation specifically, CT is less ideal than MRI because it’s less sensitive to the subtle tissue changes that characterize neurodegenerative diseases; however, CT is often done first in emergency settings or when MRI is contraindicated (such as if you have certain metal implants). The radiation exposure from one brain CT is roughly equivalent to 2-3 years of natural background radiation and is considered acceptable for diagnostic purposes when indicated, but it’s a reason to avoid repeat CTs unless medically necessary.
Understanding Common Findings in Your Report
“Cortical atrophy” or “brain atrophy” means the brain tissue has shrunk, and this is one of the most commonly reported findings in older adults. Some degree of atrophy is normal with age—everyone’s brain shrinks a bit—but the pattern and severity matter. Uniform, generalized atrophy across the brain is a sign of normal aging; focal atrophy in specific regions like the hippocampus or frontal lobe is more concerning and may correlate with cognitive decline or specific dementia types. The radiologist will often grade atrophy as mild, moderate, or severe, and these grades are based on the appearance of the brain sulci (the creases on the surface) and the size of the ventricles. Important limitation: brain atrophy visible on a scan does not automatically mean you have dementia or will develop it. Many cognitively normal older adults have noticeable atrophy, and some people with severe atrophy have normal cognition.
The relationship between brain structure and function is complex; cognition depends not just on having brain tissue present, but on the connections between regions and the integrity of the remaining tissue. “White matter hyperintensities” or “white matter changes” refer to bright spots seen on certain MRI sequences, particularly T2 and FLAIR sequences. These spots represent areas where the white matter—the insulation around nerve fibers that allows brain regions to communicate—has changed, usually due to small vessel disease (damage to tiny blood vessels), inflammation, or demyelination. Radiologists often call these changes “T2 hyperintense lesions” or describe them as “periventricular” (around the ventricles) or “subcortical” (in the deep white matter). A small number of white matter hyperintensities is common and usually considered a normal finding in people over age 60. A larger burden of white matter changes—especially if they’re extensive or associated with microhemorrhages (tiny bleeds visible as dark spots on gradient-echo sequences)—correlates with increased risk of stroke, cognitive decline, and gait problems. However, again, the presence of white matter hyperintensities does not equal dementia; many people with these findings have normal cognition, and the clinical significance depends on the total burden and location.
What Brain Scans Reveal About Dementia
Brain scans play a specific role in dementia diagnosis: they help identify treatable causes of cognitive decline (like hydrocephalus, which can sometimes be reversed with surgery, or subdural hematoma from a fall, which causes a buildup of blood that presses on the brain) and can support the diagnosis of specific dementia types through their characteristic patterns. Alzheimer’s disease typically shows hippocampal atrophy and cortical atrophy most prominent in the temporal and parietal lobes; this pattern, combined with certain biomarker tests (cerebrospinal fluid or blood tests for amyloid and tau), helps confirm Alzheimer’s diagnosis. Frontotemporal dementia shows atrophy predominantly in the frontal and anterior temporal lobes, often asymmetrically. Lewy body dementia does not typically cause the distinctive hippocampal atrophy seen in Alzheimer’s but may show other patterns, and PET imaging can reveal reduced dopamine activity in the striatum and reduced glucose metabolism in the occipital lobes. Vascular dementia is associated with large infarcts (strokes), extensive white matter disease, or multiple microinfarcts scattered throughout the brain.
A specific example: an 68-year-old woman presenting with memory loss undergoes MRI and shows selective hippocampal atrophy with relative preservation of other brain regions; combined with a positive amyloid-PET scan, this pattern strongly supports Alzheimer’s disease as the diagnosis. Multiple types of dementia can coexist—mixed pathology is common in older adults—and the scan may show evidence of multiple processes. Someone might have both hippocampal atrophy (Alzheimer’s pattern) and extensive white matter hyperintensities and an old infarct (vascular contribution). The brain scan alone cannot definitively diagnose dementia; diagnosis requires cognitive testing, a history of decline, and often cerebrospinal fluid or blood biomarkers. Think of the brain scan as one piece of evidence in a larger diagnostic puzzle rather than a definitive test.
Interpreting Size and Structure Measurements
Many brain imaging reports include measurements of specific structures, particularly the hippocampus and ventricles, sometimes compared to normative data for your age and sex. Hippocampal volume, measured in cubic centimeters, matters because the hippocampus is essential for forming new memories; atrophy here is associated with memory loss. A radiologist might report “hippocampal volume of 2.5 cm³ on the right and 2.3 cm³ on the left, which is at the 5th percentile for age and sex”—meaning your hippocampus is smaller than 95% of people your age. This measurement adds specificity to the visual assessment, though the clinical significance still depends on other factors: a person with stable, longstanding small hippocampal volumes may function differently than someone whose hippocampus has recently shrunk.
Ventricular size matters because enlarged ventricles (the fluid-filled spaces) can indicate loss of surrounding brain tissue. The Evans’ ratio compares the maximum width of the ventricles to the maximum width of the brain at the same level; higher ratios suggest ventricular enlargement. In normal pressure hydrocephalus—a condition where cerebrospinal fluid builds up and puts pressure on the brain—ventricles are enlarged, and this finding can prompt a specific diagnostic test (a lumbar puncture to measure pressure and remove fluid) and potentially a specific treatment (a shunt to drain excess fluid). The tradeoff with quantitative measurements is that they provide objective numbers, but they require comparison to normal values, and small differences may not be clinically meaningful, while visual assessment is more subjective but more experienced-eye focused on what clinically matters.
What Brain Scans Cannot Tell You
A critical limitation of brain imaging is that a normal brain scan does not rule out dementia or cognitive impairment. A patient can have significant cognitive decline from Alzheimer’s disease and have a structurally normal MRI, especially in early disease. This occurs because Alzheimer’s pathology (amyloid and tau protein accumulation) begins in the brain years before structural atrophy becomes visible; in these early stages, cognitive testing and biomarker tests (blood or cerebrospinal fluid tests for amyloid and tau) are more sensitive than structural MRI.
Conversely, a patient can have an abnormal brain scan with prominent atrophy or white matter changes and have completely normal cognition; this is not rare in older adults and highlights that the brain has significant reserve capacity. Brain imaging also cannot identify primary psychiatric illnesses (depression, anxiety, psychosis appear the same structurally whether present or absent), cannot directly measure cognitive reserve or resilience, and cannot show whether specific behaviors or symptoms are present (these require clinical observation and testing). Microinfarcts—tiny strokes that occur silently without the person noticing—may accumulate over years and contribute to cognitive decline, but many are not visible even on high-resolution MRI, particularly if they are very small or in the white matter. A warning: do not assume that a brain scan “rules out” or “confirms” Alzheimer’s disease based solely on the structural findings; diagnosis of the specific cause of cognitive decline requires integration of imaging, cognitive testing, and biomarkers.
Biomarkers and Advanced Imaging
Beyond structural MRI, specialized imaging can directly visualize Alzheimer’s pathology. Amyloid-PET shows where amyloid-beta protein has accumulated in the brain; tau-PET shows where tau protein has accumulated. In Alzheimer’s disease, amyloid tends to deposit in the cortex in a characteristic pattern, and tau tends to deposit later and more prominently in the temporal lobe and spread from there.
These biomarker imaging tests are increasingly used to confirm Alzheimer’s pathology during life, something that was only possible by brain biopsy at autopsy until recently. Amyloid-PET can be positive (showing amyloid accumulation) in cognitively normal older adults—this identifies people with amyloid pathology but no symptoms yet, called preclinical Alzheimer’s disease. This is why a positive amyloid-PET does not automatically mean cognitive decline or dementia; it means the pathology is present. A 72-year-old with normal cognition and normal MRI but positive amyloid-PET is at higher risk for future decline than someone with negative amyloid-PET, but cannot be said to have Alzheimer’s disease currently based on the scan alone.
Preparing for and Following Up on Your Scan Results
When you receive your brain scan results, ask your doctor for clarification on three key points: (1) Is this scan normal for your age and circumstances, or are there specific findings? (2) What do these findings mean in the context of your symptoms and cognitive testing? and (3) Do you need any follow-up imaging or tests? If your scan shows atrophy or white matter changes, ask whether these findings correlate with your symptoms or whether they represent normal aging. If your scan is normal but you have cognitive concerns, ask about the next steps—this might include a cognitive evaluation by a neuropsychologist, biomarker testing (blood or CSF tests), or PET imaging.
Some findings warrant urgent follow-up: a new large stroke, a tumor, increased ventricular size without explanation, or progressive atrophy on serial scans compared to a prior scan done years earlier. Other findings, like stable mild atrophy or a small number of white matter hyperintensities in an older adult with normal cognition, may require only routine follow-up. Request a copy of your imaging CD (most hospitals provide this) and your formal radiology report; having these allows you to review the findings with multiple specialists if needed and permits comparison if repeat imaging is done in the future.
- —
